Département d'Infectiologie de Terrain, Unité de Parasitologie, Institut de Recherche Biomédicale des Armées, Marseille, France.
Malar J. 2013 Jun 7;12:189. doi: 10.1186/1475-2875-12-189.
Although the World Health Organization recommends replacing quinine (QN) by artesunate due to its increased efficacy and the higher tolerance to the drug in both adults and children, QN remains a first-line treatment for severe malaria, especially in Africa. Investigations of microsatellite Pfnhe-1 ms4760 polymorphisms in culture-adapted isolates from around the world have revealed that an increase in the number of DNNND amino acid motifs was associated with decreased QN susceptibility, whereas an increase in the number of DDNHNDNHNND motifs was associated with increased QN susceptibility.
In this context, to further analyse associations between Pfnhe-1 ms4760 polymorphisms and QN susceptibility, 393 isolates freshly collected between October 2009 and January 2010 and July 2010 and February 2011, respectively, at the Hôpital Principal de Dakar, Senegal were assessed ex vivo for QN susceptibility, and their genes were amplified and sequenced.
Of the 393 Plasmodium falciparum clinical isolates collected, 145 were successfully cultured. The 145 QN IC50s ranged from 2.1 to 1291 nM, and 17 isolates (11.7%) exceed the QN reduced susceptibility threshold of 611 nM. Among the 393 P. falciparum clinical isolates, 47 different alleles were observed. The three most prevalent profiles were ms4760-1 (no = 72; 18.3%), ms4760-3 (no = 65; 16.5%) and ms4760-7 (no = 40; 10.2%). There were no significant associations observed between QN IC50 values and i) the number of repeats of DNNND in block II (p = 0.0955, Kruskal-Wallis test); ii) the number of repeats of DDNHNDNHNND in block V (p = 0.1455, Kruskal-Wallis test); or iii) ms4760 profiles (p = 0.1809, Kruskal-Wallis test).
Pfnhe-1 ms4760 was highly diverse in parasite isolates from Dakar (47 different profiles). Three profiles (ms4760-1, ms4760-3 and ms4760-7) were predominant. The number of repeats for block II (DNNND) or block V (DDNHNDNHNND) was not significantly associated with QN susceptibility. New studies, and especially in vivo studies, are necessary to confirm the role of Pfnhe-1 ms4760 as a marker of QN resistance.
尽管世界卫生组织建议用青蒿琥酯替代奎宁(QN),因为其在成人和儿童中的疗效更高,且对药物的耐受性更高,但 QN 仍然是治疗重症疟疾的一线药物,尤其是在非洲。对世界各地培养适应株的 PfNhe-1 ms4760 微卫星多态性的研究表明,增加 DNNND 氨基酸基序的数量与 QN 敏感性降低有关,而增加 DDNHNDNHNND 基序的数量与 QN 敏感性增加有关。
在这种情况下,为了进一步分析 PfNhe-1 ms4760 多态性与 QN 敏感性之间的关联,对 2009 年 10 月至 2010 年 1 月以及 2010 年 7 月至 2011 年 2 月在塞内加尔达喀尔主要医院新采集的 393 株寄生虫分离株进行了体外 QN 敏感性评估,并对其基因进行了扩增和测序。
在采集的 393 株疟原虫临床分离株中,有 145 株成功培养。145 株 QN IC50 值范围为 2.1 至 1291 nM,有 17 株(11.7%)超过 611 nM 的 QN 降低敏感性阈值。在 393 株疟原虫临床分离株中,观察到 47 种不同的等位基因。最常见的三种基因型分别为 ms4760-1(无=72;18.3%)、ms4760-3(无=65;16.5%)和 ms4760-7(无=40;10.2%)。在 QN IC50 值与 i)块 II 中 DNNND 重复次数(p=0.0955,Kruskal-Wallis 检验);ii)块 V 中 DDNHNDNHNND 重复次数(p=0.1455,Kruskal-Wallis 检验);或 iii)ms4760 基因型(p=0.1809,Kruskal-Wallis 检验)之间未观察到显著相关性。
达喀尔寄生虫分离株中的 PfNhe-1 ms4760 高度多样化(47 种不同的基因型)。三种基因型(ms4760-1、ms4760-3 和 ms4760-7)占主导地位。块 II(DNNND)或块 V(DDNHNDNHNND)的重复次数与 QN 敏感性无显著相关性。需要进行新的研究,尤其是体内研究,以确认 PfNhe-1 ms4760 作为 QN 耐药性标志物的作用。